An estimated 491 000 fewer people than expected began antihypertensive medications in the UK between March 2020 and July 2021 during the COVID-19 pandemic. The decline, reported in Nature Medicine, could result in more than 13 000 additional cardiovascular disease events, including nearly 2300 myocardial infarctions and 3500 strokes, should these patients remain untreated over their lifetimes, the authors predicted.
Source: JAMA Online First